Relay Therapeutics, Inc. (RLAY): Shareholders' Equity
$567.06M
As of 2025-12-31
$890.01M
As of 2026-06-30
-15.8%
3-year compound annual growth
-5.8%
5-year compound annual growth
| Period ended | Shareholders' Equity | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $567.06M | -27.1% | 2026-02-26, Balance as of period end |
| 2024-12-31 | $777.79M | +3.4% | 2026-02-26, Balance as of period end |
| 2023-12-31 | $752.00M | -20.9% | 2026-02-26, Balance as of period end |
| 2022-12-31 | $950.22M | +5.8% | 2025-02-26, Balance as of period end |
| 2021-12-31 | $897.81M | +17.6% | 2024-02-22, Balance as of period end |
| 2020-12-31 | $763.29M | n/m | 2023-02-23, Balance as of period end |
| 2019-12-31 | -$180.44M | n/a | 2022-02-24, Balance as of period end |
Shareholders' Equity at similar companies
| Company | Year ended | Shareholders' Equity | Change YoY |
|---|---|---|---|
| Relay Therapeutics, Inc. (RLAY) | 2025-12-31 | $567.06M | -27.1% |
| Lineage Cell Therapeutics, Inc. (LCTX) | 2025-12-31 | $43.35M | -43.7% |
| Pelthos Therapeutics Inc. (PTHS) | 2025-12-31 | $38.88M | n/m |
| LENZ Therapeutics, Inc. (LENZ) | 2025-12-31 | $284.34M | +39.3% |
| Alector, Inc. (ALEC) | 2025-12-31 | $30.65M | -75.8% |
| Caribou Biosciences, Inc. (CRBU) | 2025-12-31 | $122.17M | -51.7% |
| TScan Therapeutics, Inc. (TCRX) | 2025-12-31 | $123.12M | -48.9% |
| Alpha Cognition Inc. (ACOG) | 2025-12-31 | $62.53M | +59.9% |
| Taysha Gene Therapies, Inc. (TSHA) | 2025-12-31 | $246.94M | +245.2% |
Compare RLAY, LCTX, PTHS, LENZ side by side · Screen every company in Biological Products, (No Diagnostic Substances) ↗